Goldman Sachs’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-28,200
| Closed | -$938K | – | 5651 |
|
|
2020
Q2 | $938K | Buy |
+28,200
| New | +$898K | ﹤0.01% | 3996 |
|
|
2018
Q3 | – | Sell |
-3,100
| Closed | -$63K | – | 5908 |
|
|
2018
Q2 | $63K | Sell |
3,100
-1,100
| -26% | -$23.6K | ﹤0.01% | 5304 |
|
|
2018
Q1 | $76K | Hold |
4,200
| – | – | ﹤0.01% | 5367 |
|
|
2017
Q4 | $59K | Sell |
4,200
-5,400
| -56% | -$73K | ﹤0.01% | 5906 |
|
|
2017
Q3 | $178K | Sell |
9,600
-20,500
| -68% | -$343K | ﹤0.01% | 5818 |
|
|
2017
Q2 | $509K | Buy |
30,100
+18,200
| +153% | +$277K | ﹤0.01% | 5086 |
|
|
2017
Q1 | $159K | Sell |
11,900
-1,000
| -8% | -$15.7K | ﹤0.01% | 5847 |
|
|
2016
Q4 | $194K | Buy |
12,900
+1,500
| +13% | +$19.8K | ﹤0.01% | 5789 |
|
|
2016
Q3 | $133K | Buy |
11,400
+2,200
| +24% | +$25.9K | ﹤0.01% | 6080 |
|
|
2016
Q2 | $99K | Sell |
9,200
-41,700
| -82% | -$430K | ﹤0.01% | 6134 |
|
|
2016
Q1 | $470K | Sell |
50,900
-17,400
| -25% | -$187K | ﹤0.01% | 4801 |
|
|
2015
Q4 | $1.01M | Sell |
68,300
-122,600
| -64% | -$2.05M | ﹤0.01% | 4281 |
|
|
2015
Q3 | $3.13M | Buy |
190,900
+103,700
| +119% | +$2.12M | ﹤0.01% | 3337 |
|
|
2015
Q2 | $1.99M | Buy |
87,200
+4,600
| +6% | +$91.6K | ﹤0.01% | 3826 |
|
|
2015
Q1 | $1.26M | Buy |
82,600
+49,900
| +153% | +$648K | ﹤0.01% | 4243 |
|
|
2014
Q4 | $394K | Sell |
32,700
-52,800
| -62% | -$603K | ﹤0.01% | 5510 |
|
|
2014
Q3 | $970K | Buy |
85,500
+6,400
| +8% | +$73K | ﹤0.01% | 4642 |
|
|
2014
Q2 | $956K | Sell |
79,100
-30,500
| -28% | -$360K | ﹤0.01% | 4730 |
|
|
2014
Q1 | $1.28M | Sell |
109,600
-49,800
| -31% | -$843K | ﹤0.01% | 4426 |
|
|
2013
Q4 | $2.82M | Sell |
159,400
-117,900
| -43% | -$1.98M | ﹤0.01% | 3711 |
|
|
2013
Q3 | $3.99M | Buy |
277,300
+174,600
| +170% | +$2.67M | ﹤0.01% | 3177 |
|
|
2013
Q2 | $1.55M | Buy |
+102,700
| New | +$1.36M | ﹤0.01% | 3966 |
|
Goldman Sachs's MNTA Position: Q4 2020 in Review
Goldman Sachs sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 1,610,731 shares — an estimated $84.5M sold.
Goldman Sachs first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $84.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Goldman Sachs reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Goldman Sachs sold 1,610,731 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $84.5M.
- Goldman Sachs first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Goldman Sachs's Momenta Pharmaceuticals, Inc. position peaked at $84.5M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.